See more : Canadian Utilities Limited 2ND PFD SER DD% (CNUTF) Income Statement Analysis – Financial Results
Complete financial analysis of North America Frac Sand, Inc. (NAFS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of North America Frac Sand, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Jiangsu Phoenix Property Investment Company Limited (600716.SS) Income Statement Analysis – Financial Results
- Exco Technologies Limited (EXCOF) Income Statement Analysis – Financial Results
- The Toronto-Dominion Bank (TD) Income Statement Analysis – Financial Results
- Telecom Argentina S.A. (TECO2.BA) Income Statement Analysis – Financial Results
- Livzon Pharmaceutical Group Inc. (1513.HK) Income Statement Analysis – Financial Results
North America Frac Sand, Inc. (NAFS)
About North America Frac Sand, Inc.
North America Frac Sand, Inc., doing business as Voycare, provides telemedicine and medical tourism services in the United States. It enables overseas patients gain access to health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery, and wellness. The company primarily serves Chinese outbound travelers to North and South America. The company was founded in 2019 and is based in Covina, California with office in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 137.31K | 0.00 | 0.00 | 716.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00 | 1.75K | 0.00 |
| Cost of Revenue | 64.05K | 0.00 | 0.00 | 216.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 73.26K | 0.00 | 0.00 | 500.16K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00 | 1.75K | 0.00 |
| Gross Profit Ratio | 53.35% | 0.00% | 0.00% | 69.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 4.51K | 161.52K | 0.00 | 0.00 | 144.29K | 259.25K | 65.62K | 38.81K | 67.09K | 20.52M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 363.61K | 2.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.58K | 0.00 | 0.00 |
| SG&A | 775.76K | 320.00K | 363.61K | 2.24M | 224.20K | 33.53K | 144.29K | 259.25K | 65.62K | 38.81K | 67.09K | 20.52M | 3.61K | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 190.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 775.76K | 320.00K | 363.61K | 2.24M | 224.20K | 33.53K | 228.07K | 316.41K | 65.62K | 38.81K | 67.09K | 20.52M | 3.61K | 0.00 |
| Cost & Expenses | 839.81K | 320.00K | 363.61K | 2.46M | 224.20K | 33.53K | 228.07K | 316.41K | 65.62K | 38.81K | 67.09K | 20.52M | 3.61K | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 169.91K | 31.37K | 184.65K | 322.88K | 17.19K | 43.46K | 14.53K | 12.66K | 0.00 | 0.00 | 0.00 | 10.67K | 0.00 | 0.00 |
| Depreciation & Amortization | 5.24K | 228.49K | 363.61K | 1.74M | 171.86K | 0.00 | 1.54M | 1.54M | -1.40K | 13.74M | 55.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | -623.33K | -320.00K | 0.00 | 93.36K | 13.70M | -33.53K | 1.32M | -125.74K | -65.42K | 13.70M | -122.09K | -20.52M | -1.86K | 0.00 |
| EBITDA Ratio | -453.97% | 0.00% | 0.00% | -243.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8,209,060.40% | -106.17% | 0.00% |
| Operating Income | -702.50K | -320.00K | -363.61K | -1.74M | -224.20K | -33.53K | -228.07K | -316.41K | -64.42K | -38.81K | -122.09K | -20.52M | -1.86K | 0.00 |
| Operating Income Ratio | -511.63% | 0.00% | 0.00% | -243.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8,209,060.40% | -106.17% | 0.00% |
| Total Other Income/Expenses | -95.98K | -87.63K | 1.20M | -229.51K | 13.91M | -40.37K | -14.53K | -1.35M | 0.00 | -13.74M | 0.00 | -10.67K | 0.00 | 0.00 |
| Income Before Tax | -798.48K | -407.63K | 838.11K | -1.97M | 13.69M | -73.90K | -242.60K | -1.67M | -64.42K | -13.78M | -122.09K | -20.53M | -1.86K | 0.00 |
| Income Before Tax Ratio | -581.54% | 0.00% | 0.00% | -275.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8,213,328.40% | -106.17% | 0.00% |
| Income Tax Expense | -1.00 | -228.49K | -363.61 | 11.67K | -171.86K | 0.00 | -1.54M | 12.66K | 200.00 | 0.00 | -55.00K | 0.00 | 0.00 | 0.00 |
| Net Income | -798.48K | -407.63K | 838.11K | -1.98M | 13.69M | -73.90K | -242.60K | -1.67M | -64.42K | -13.78M | -122.09K | -20.53M | -1.86K | 0.00 |
| Net Income Ratio | -581.54% | 0.00% | 0.00% | -276.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8,213,328.40% | -106.17% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.30 | 0.00 | 0.00 | -0.03 | -0.02 | -21.14 | -4.72 | -44.44K | -619.33 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.30 | 0.00 | 0.00 | -0.03 | -0.02 | -21.14 | -4.72 | -44.44K | -619.33 | 0.00 |
| Weighted Avg Shares Out | 770.35M | 495.74M | 478.33M | 144.38M | 45.44M | 70.07M | 64.68M | 50.25M | 2.99M | 651.99K | 25.89K | 462.00 | 3.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 770.35M | 495.74M | 478.33M | 144.38M | 45.44M | 70.07M | 64.68M | 50.25M | 2.99M | 651.99K | 25.89K | 462.00 | 3.00 | 0.00 |
Attorney Letter with Respect to Current Information
Source: https://incomestatements.info
Category: Stock Reports